Medtronic Current Ratio 2012-2026 | MDT
Current and historical current ratio for Medtronic (MDT) from 2012 to 2026. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Medtronic current ratio for the three months ending January 31, 2026 was 0.00.
| Medtronic Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2026-01-31 | $0.00B | 0.00 | |
| 2025-10-31 | $24.00B | $9.94B | 2.42 |
| 2025-07-31 | $23.22B | $11.53B | 2.01 |
| 2025-04-30 | $23.81B | $12.88B | 1.85 |
| 2025-01-31 | $22.51B | $11.84B | 1.90 |
| 2024-10-31 | $22.44B | $12.20B | 1.84 |
| 2024-07-31 | $21.95B | $10.29B | 2.13 |
| 2024-04-30 | $21.94B | $10.79B | 2.03 |
| 2024-01-31 | $22.51B | $9.79B | 2.30 |
| 2023-10-31 | $22.08B | $9.66B | 2.29 |
| 2023-07-31 | $21.87B | $9.05B | 2.42 |
| 2023-04-30 | $21.68B | $9.05B | 2.40 |
| 2023-01-31 | $25.36B | $14.42B | 1.76 |
| 2022-10-31 | $25.40B | $14.47B | 1.76 |
| 2022-07-31 | $22.14B | $14.05B | 1.58 |
| 2022-04-30 | $23.06B | $12.39B | 1.86 |
| 2022-01-31 | $23.30B | $8.93B | 2.61 |
| 2021-10-31 | $22.73B | $7.80B | 2.91 |
| 2021-07-31 | $22.43B | $7.76B | 2.89 |
| 2021-04-30 | $22.55B | $8.51B | 2.65 |
| 2021-01-31 | $26.35B | $12.53B | 2.10 |
| 2020-10-31 | $26.04B | $12.07B | 2.16 |
| 2020-07-31 | $24.51B | $13.09B | 1.87 |
| 2020-04-30 | $22.03B | $10.37B | 2.13 |
| 2020-01-31 | $24.04B | $8.74B | 2.75 |
| 2019-10-31 | $22.65B | $8.17B | 2.77 |
| 2019-07-31 | $22.71B | $8.52B | 2.67 |
| 2019-04-30 | $21.97B | $8.47B | 2.59 |
| 2019-01-31 | $20.88B | $8.85B | 2.36 |
| 2018-10-31 | $21.65B | $8.46B | 2.56 |
| 2018-07-31 | $22.46B | $9.11B | 2.47 |
| 2018-04-30 | $22.98B | $10.08B | 2.28 |
| 2018-01-31 | $26.61B | $10.93B | 2.43 |
| 2017-10-31 | $25.16B | $10.50B | 2.40 |
| 2017-07-31 | $24.78B | $15.15B | 1.64 |
| 2017-04-30 | $24.87B | $14.26B | 1.74 |
| 2017-01-31 | $22.42B | $12.67B | 1.77 |
| 2016-10-31 | $22.53B | $9.60B | 2.35 |
| 2016-07-31 | $23.50B | $7.90B | 2.98 |
| 2016-04-30 | $23.60B | $7.17B | 3.29 |
| 2016-01-31 | $27.57B | $8.14B | 3.39 |
| 2015-10-31 | $28.72B | $8.13B | 3.54 |
| 2015-07-31 | $29.15B | $7.66B | 3.81 |
| 2015-04-30 | $30.84B | $9.17B | 3.36 |
| 2015-01-31 | $38.16B | $5.61B | 6.80 |
| 2014-10-31 | $21.60B | $6.95B | 3.11 |
| 2014-07-31 | $20.77B | $5.43B | 3.82 |
| 2014-04-30 | $21.21B | $5.56B | 3.82 |
| 2014-01-31 | $20.39B | $5.63B | 3.62 |
| 2013-10-31 | $19.48B | $5.50B | 3.55 |
| 2013-07-31 | $18.09B | $4.29B | 4.22 |
| 2013-04-30 | $17.85B | $3.95B | 4.52 |
| 2013-01-31 | $9.16B | $6.96B | 1.32 |
| 2012-10-31 | $9.44B | $6.62B | 1.43 |
| 2012-07-31 | $9.18B | $5.81B | 1.58 |
| 2012-04-30 | $16.34B | $5.93B | 2.76 |
| 2012-01-31 | $9.31B | $4.56B | 2.04 |
| 2011-10-31 | $9.01B | $4.73B | 1.90 |
| 2011-07-31 | $9.29B | $4.81B | 1.93 |
| 2011-04-30 | $9.15B | $4.73B | 1.94 |
| 2011-01-31 | $9.99B | $6.41B | 1.56 |
| 2010-10-31 | $9.89B | $5.90B | 1.68 |
| 2010-07-31 | $10.00B | $5.61B | 1.78 |
| 2010-04-30 | $9.84B | $5.12B | 1.92 |
| 2010-01-31 | $7.98B | $3.79B | 2.10 |
| 2009-10-31 | $7.31B | $3.28B | 2.23 |
| 2009-07-31 | $7.28B | $3.13B | 2.33 |
| 2009-04-30 | $7.45B | $3.15B | 2.37 |
| 2009-01-31 | $7.21B | $3.17B | 2.28 |
| 2008-10-31 | $6.50B | $2.91B | 2.23 |
| 2008-07-31 | $7.40B | $3.72B | 1.99 |
| 2008-04-30 | $7.32B | $3.54B | 2.07 |
| 2008-01-31 | $6.68B | $3.54B | 1.89 |
| 2007-10-31 | $10.54B | $2.65B | 3.98 |
| 2007-07-31 | $7.67B | $2.04B | 3.76 |
| 2007-04-30 | $7.92B | $2.56B | 3.09 |
| 2007-01-31 | $8.21B | $2.70B | 3.04 |
| 2006-10-31 | $8.42B | $2.70B | 3.13 |
| 2006-07-31 | $10.43B | $4.44B | 2.35 |
| 2006-04-30 | $10.38B | $4.41B | 2.36 |
| 2006-01-31 | $8.93B | $4.87B | 1.83 |
| 2005-10-31 | $8.12B | $4.90B | 1.66 |
| 2005-07-31 | $7.13B | $3.60B | 1.98 |
| 2005-04-30 | $7.42B | $3.38B | 2.20 |
| 2005-01-31 | $6.73B | $2.66B | 2.53 |
| 2004-10-31 | $6.37B | $2.49B | 2.56 |
| 2004-07-31 | $5.87B | $4.30B | 1.37 |
| 2004-04-30 | $5.31B | $4.24B | 1.25 |
| 2004-01-31 | $4.64B | $4.07B | 1.14 |
| 2003-10-31 | $4.39B | $3.95B | 1.11 |
| 2003-07-31 | $4.37B | $1.81B | 2.41 |
| 2003-04-30 | $4.69B | $1.90B | 2.47 |
| 2003-01-31 | $4.58B | $1.75B | 2.61 |
| 2002-10-31 | $4.20B | $1.70B | 2.47 |
| 2002-07-31 | $4.01B | $3.89B | 1.03 |
| 2002-04-30 | $3.49B | $3.99B | 0.88 |
| 2002-01-31 | $3.31B | $3.64B | 0.91 |
| 2001-10-31 | $3.13B | $3.56B | 0.88 |
| 2001-07-31 | $3.91B | $1.32B | 2.97 |
| 2001-04-30 | $3.76B | $1.36B | 2.76 |
| 2001-01-31 | $3.08B | $0.95B | 3.25 |
| 2000-10-31 | $3.21B | $1.02B | 3.15 |
| 2000-07-31 | $3.13B | $0.96B | 3.24 |
| 2000-04-30 | $3.04B | $0.99B | 3.05 |
| 2000-01-31 | $2.73B | $1.12B | 2.44 |
| 1999-10-31 | $2.52B | $1.10B | 2.29 |
| 1999-07-31 | $2.40B | $0.98B | 2.44 |
| 1999-04-30 | $2.40B | $0.99B | 2.42 |
| 1999-01-31 | $2.53B | $1.17B | 2.17 |
| 1998-10-31 | $2.27B | $0.77B | 2.93 |
| 1998-07-31 | $1.60B | $0.58B | 2.76 |
| 1998-04-30 | $1.55B | $0.57B | 2.71 |
| 1998-01-31 | $1.50B | $0.60B | 2.49 |
| 1997-10-31 | $1.39B | $0.50B | 2.78 |
| 1997-07-31 | $1.32B | $0.52B | 2.56 |
| 1997-04-30 | $1.24B | $0.52B | 2.39 |
| 1997-01-31 | $1.51B | $0.49B | 3.08 |
| 1996-10-31 | $1.47B | $0.47B | 3.12 |
| 1996-07-31 | $1.43B | $0.46B | 3.11 |
| 1996-04-30 | $1.34B | $0.53B | 2.56 |
| 1996-01-31 | $1.24B | $0.39B | 3.17 |
| 1995-10-31 | $1.20B | $0.39B | 3.06 |
| 1995-07-31 | $1.23B | $0.43B | 2.83 |
| 1995-04-30 | $1.10B | $0.46B | 2.42 |
| 1995-01-31 | $0.91B | $0.39B | 2.36 |
| 1994-10-31 | $0.88B | $0.40B | 2.22 |
| 1994-07-31 | $0.82B | $0.42B | 1.97 |
| 1994-04-30 | $0.85B | $0.44B | 1.93 |
| 1994-01-31 | $0.79B | $0.28B | 2.80 |
| 1993-10-31 | $0.71B | $0.25B | 2.80 |
| 1993-07-31 | $0.72B | $0.29B | 2.51 |
| 1993-04-30 | $0.78B | $0.35B | 2.21 |
| 1993-01-31 | $0.81B | $0.28B | 2.90 |
| 1992-10-31 | $0.79B | $0.27B | 2.87 |
| 1992-07-31 | $0.68B | $0.27B | 2.58 |
| 1992-04-30 | $0.70B | $0.31B | 2.26 |
| 1992-01-31 | $0.67B | $0.28B | 2.37 |
| 1991-10-31 | $0.63B | $0.27B | 2.34 |
| 1991-07-31 | $0.60B | $0.26B | 2.33 |
| 1991-04-30 | $0.61B | $0.29B | 2.10 |
| 1991-01-31 | $0.57B | $0.27B | 2.13 |
| 1990-10-31 | $0.57B | $0.28B | 2.00 |
| 1990-07-31 | $0.50B | $0.27B | 1.86 |
| 1990-04-30 | $0.51B | $0.26B | 1.91 |
| 1990-01-31 | $0.44B | $0.24B | 1.87 |
| 1989-10-31 | $0.43B | $0.23B | 1.90 |
| 1989-07-31 | $0.42B | $0.22B | 1.93 |
| 1989-04-30 | $0.42B | $0.23B | 1.82 |
| 1989-01-31 | $0.40B | $0.20B | 2.03 |
| 1988-10-31 | $0.38B | $0.19B | 2.01 |
| 1988-07-31 | $0.41B | $0.23B | 1.80 |
| 1988-04-30 | $0.42B | $0.19B | 2.23 |
| 1988-01-31 | $0.37B | $0.15B | 2.38 |
| 1987-10-31 | $0.37B | $0.14B | 2.55 |
| 1987-07-31 | $0.37B | $0.13B | 2.84 |
| 1987-04-30 | $0.37B | $0.13B | 2.91 |
| 1986-04-30 | $0.36B | $0.13B | 2.67 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $127.548B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.921B | 25.86 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |